We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.76B
1-Year Est. Return
23.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+23.12%
3 Year Est. Return
+69.23%
5 Year Est. Return
+84.02%
10 Year Est. Return
+273.29%
AUM
$3.62B
AUM Growth
+$109M
(+3.1%)
Cap. Flow
+$29.8M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$9.09M |
| 2 |
General Mills
GIS
|
+$8.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.22M |
| 4 |
Cencora
COR
|
+$4.97M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.8M |
| 2 |
DNB
Dun & Bradstreet
DNB
|
+$6.42M |
| 3 |
PNC Financial Services
PNC
|
+$6.23M |
| 4 |
PepsiCo
PEP
|
+$5.76M |
| 5 |
Walt Disney
DIS
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.38% |
| 2 | Healthcare | 15.13% |
| 3 | Technology | 14.47% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
BorgWarner
BWA
$13.1B
| $3.36M | 0.09% |
90,126
-1,972
| -2% | -$71.5K |
|
252
Coca-Cola
KO
$377B
| $3.36M | 0.09% |
74,912
+12,267
| +20% | +$542K |
|
253
RB Global
RBA
$20.4B
| $3.35M | 0.09% |
116,601
+3,601
| +3% | +$112K |
|
254
Illumina
ILMN
$31B
| $3.31M | 0.09% |
19,594
+621
| +3% | +$107K |
|
255
Monster Beverage
MNST
$94.3B
| $3.3M | 0.09% |
132,956
-62,432
| -32% | -$1.5M |
|
256
West Pharmaceutical
WST
$24B
| $3.29M | 0.09% |
34,780
+23,118
| +198% | +$2.13M |
|
257
Rollins
ROL
$18.3B
| $3.28M | 0.09% |
181,188
-1,913
| -1% | -$34.3K |
|
258
Clorox
CLX
$11.6B
| $3.25M | 0.09% |
24,390
-379
| -2% | -$51.1K |
|
259
Barclays
BCS
$92.7B
| $3.22M | 0.09% |
319,617
+107,464
| +51% | +$1.1M |
|
260
S&P Global
SPGI
$121B
| $3.21M | 0.09% |
21,988
-1,218
| -5% | -$169K |
|
261
Halliburton
HAL
$26.9B
| $3.2M | 0.09% |
74,962
-7,943
| -10% | -$365K |
|
262
Dollar Tree
DLTR
$24.4B
| $3.19M | 0.09% |
45,611
-4,218
| -8% | -$326K |
|
263
Unum
UNM
$13.6B
| $3.18M | 0.09% |
68,125
-7,321
| -10% | -$337K |
|
|
BECN
264
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.16M | 0.09% |
64,486
-797
| -1% | -$39.2K |
|
265
Citizens Financial Group
CFG
$30.3B
| $3.14M | 0.09% |
87,892
-3,796
| -4% | -$135K |
|
266
International Flavors & Fragrances
IFF
$20.2B
| $3.13M | 0.09% |
23,158
+150
| +0.7% | +$20.3K |
|
267
Invesco Senior Loan ETF
BKLN
$6.97B
| $3.1M | 0.09% |
133,972
+27,190
| +25% | +$632K |
|
268
PRA Group
PRAA
$663M
| $3.06M | 0.08% |
80,657
-972
| -1% | -$33.9K |
|
269
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $3.05M | 0.08% |
38,543
+9,077
| +31% | +$692K |
|
270
Cognizant
CTSH
$24.9B
| $3.03M | 0.08% |
45,695
+5,087
| +13% | +$323K |
|
271
Applied Materials
AMAT
$403B
| $3.03M | 0.08% |
73,286
-9,054
| -11% | -$385K |
|
272
HDFC Bank
HDB
$123B
| $3M | 0.08% |
138,204
+73,856
| +115% | +$1.54M |
|
273
Palo Alto Networks
PANW
$270B
| $2.96M | 0.08% |
132,948
-5,676
| -4% | -$115K |
|
|
SHPG
274
DELISTED
Shire pic
SHPG
| $2.94M | 0.08% |
17,797
+6,917
| +64% | +$1.21M |
|
275
O'Reilly Automotive
ORLY
$72.9B
| $2.88M | 0.08% |
197,400
-32,445
| -14% | -$530K |
|
Similar funds
SWP
MOACM
MERSOM
MU
MC
PCIA
PEA
HI
Oppenheimer Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
- Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
- Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
- Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
- Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
- Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
- Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.
Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.